InsiderClue
Insiders · Profile

Rock Springs Capital Management LP

10% owner at Xilio Therapeutics · 10% owner at Atea Pharmaceuticals · 10% owner at Enliven Therapeutics · and 1 more. Filing since 2 Apr 2018. CIK 0001595725

XLO Xilio Therapeutics, Inc. 10% owner · 1 trade AVIR Atea Pharmaceuticals, Inc. 10% owner · 1 trade ELVN Enliven Therapeutics, Inc. 10% owner · 1 trade FIXX Q32 Bio Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
XLO Xilio Therapeutics, Inc.
26 Oct 2021
10% owner
Bought
500,000
$8.00M
66.1%
AVIR Atea Pharmaceuticals, Inc.
3 Nov 2020
10% owner
Bought
250,000
$6.00M
17.8%
ELVN Enliven Therapeutics, Inc.
16 Mar 2020
10% owner
Bought
250,000
$4.00M
91.4%
FIXX Q32 Bio Inc.
2 Apr 2018
10% owner
Bought
250,000
$4.00M
63.2%
4 decisions on file.